Literature DB >> 380430

Poststreptococcal acute glomerulonephritis: fact and controversy.

A R Nissenson, L J Baraff, R N Fine, D W Knutson.   

Abstract

Poststreptococcal acute glomerulonephritis is prototypic of the immunologic glomerulonephritides. It most commonly follows streptococcal infection of the pharynx or skin. The diagnosis is usually not difficult when a nephritic clinical presentation (with such manifestations as hematuria, edema, and hypertension) is associated with serologic evidence of recent streptococcal infection and a depressed serum complement concentration. Currently, however, the nephritogenic antigen(s) has not been identified and has not been shown to be the same antigen for all nephritogenic streptococci; it may not even be a part of the infecting organism. The development of a vaccine to prevent this illness from occurring is therefore still not possible. Whether poststreptococcal acute glomerulonephritis progresses to chronic renal failure is still uncertain. Painstaking laboratory research together with careful, prospective long-term follow-up studies of patients with poststreptococcal acute glomerulonephritis may provide some of the answers to these critical questions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380430     DOI: 10.7326/0003-4819-91-1-76

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Post-streptococcal acute glomerulonephritis in Chile--20 years of experience.

Authors:  Ximena Berríos; Edda Lagomarsino; Eric Solar; Gloria Sandoval; Beatriz Guzmán; Ingrid Riedel
Journal:  Pediatr Nephrol       Date:  2003-12-20       Impact factor: 3.714

Review 2.  Acute and crescentic glomerulonephritis.

Authors:  M Vijayakumar
Journal:  Indian J Pediatr       Date:  2002-12       Impact factor: 1.967

3.  A rare adult case of poststreptococcal acute glomerulonephritis with a retropharyngeal abscess.

Authors:  Tsuyoshi Takashima; Sae Hirata; Mai Nonaka; Keiichiro Matsumoto; Yuki Awanami; Masatora Yamasaki; Makoto Fukuda; Motoaki Miyazono; Yuji Ikeda
Journal:  CEN Case Rep       Date:  2017-03-27

4.  Clinical profile of acute glomerulonephritis in children.

Authors:  M Singh; E Azizi; M A Qureshi; L S Arya
Journal:  Indian J Pediatr       Date:  1984 Sep-Oct       Impact factor: 1.967

Review 5.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

6.  The development of a community-based public health response to an outbreak of post-streptococcal glomerulonephritis in a First Nations community.

Authors:  Jeffrey Jacob; Natalie Bocking; Ruben Hummelen; Jenna Poirier; Len Kelly; Sharen Madden; Yoko Schreiber
Journal:  Can Commun Dis Rep       Date:  2021-07-08

7.  Concurrent Acute Glomerulonephritis and Retropharyngeal Abscess in 10 Year Boy: A Case Report.

Authors:  Sudha Yadav; Deepali Garg; Narain Das Vaswani; Jaya Shankar Kaushik; Seema Rohilla
Journal:  J Clin Diagn Res       Date:  2017-07-01

8.  Lymphocyte cell subpopulations during acute post-streptococcal glomerulonephritis: cell surface antigens and binding of streptococcal membrane antigens and C-reactive protein.

Authors:  R C Williams; I Van de Rijn; H Reid; T Poon-King; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

Review 9.  The role of nephritis-associated plasmin receptor (NAPlr) in glomerulonephritis associated with streptococcal infection.

Authors:  Takashi Oda; Nobuyuki Yoshizawa; Kazuo Yamakami; Yutaka Sakurai; Hanako Takechi; Kojiro Yamamoto; Naoki Oshima; Hiroo Kumagai
Journal:  J Biomed Biotechnol       Date:  2012-10-14

10.  Post-streptococcal glomerulonephritis leading to posterior reversible encephalopathy syndrome: a case report.

Authors:  Madura Adikari; Dilani Priyangika; Indika Marasingha; Sharmila Thamotheram; Gayani Premawansa
Journal:  BMC Res Notes       Date:  2014-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.